Close Menu

HIV

NEW YORK (GenomeWeb News) – Life Technologies today announced a collaboration with the Southern African Treatment and Resistance Network (SATuRN) covering sequencing-based diagnostics for HIV patients in Africa.

NEW YORK (GenomeWeb News) – Oxford Gene Technology today announced it has been awarded two grants totaling €3 million ($3.6 million) to provide genomic analysis and commercialization services for two international studies.

Researchers from several institutions have developed a high-resolution melting assay that can provide measurements of HIV diversity that are highly concordant with equivalent sequencing-based measurements at a fraction of the cost.

The National Institutes of Health last month announced that it is seeking research grant applications for projects related to the identification of microRNAs and other non-coding RNAs as biomarkers in the early detection of cancer.

Quest Diagnostics has launched an HIV tropism test using next-generation sequencing as part of a larger effort to develop NGS-based tests.

French diagnostics and theranostics firm Theradiag this week announced that it has acquired Prestizia, a five-employee subsidiary of privately held French investment firm Holding Incubatrice Biotechnology and Pharmacy, in a bid to expand its technology base to include microRNAs.

University of Pennsylvania engineer Changchun Liu is planning to use a mentored career development grant from the National Institute of Allergy and Infectious Diseases to develop a non-instrumented, isothermal, microfluidic sample-to-answer assay to detect HIV virus.

Health management-services and diagnostics firm Alere is developing a pair of nucleic acid testing platforms, representing the company's first major move into the molecular diagnostics space, according to recent company presentations.

Cepheid last week reported a 28 percent spike in first-quarter revenues driven primarily by strong sales in its clinical diagnostics business, including record sequential growth in clinical reagent sales.

Pages

A new blood test might be able to detect the presence of some 50 cancers, according to New Scientist.

Undark looks into how coronavirus-related shutdowns are affecting field researchers.

In PNAS this week: strategies to design DNA oligonucleotide probes for bacteria, Vibrio cholerae evolution in Haiti, and more.

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.